ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 290 filers reported holding ALKERMES PLC in Q4 2015. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $232,000 | -0.9% | 4,000 | 0.0% | 0.22% | -3.1% |
Q1 2017 | $234,000 | +5.4% | 4,000 | 0.0% | 0.23% | +7.6% |
Q4 2016 | $222,000 | +62.0% | 4,000 | 0.0% | 0.21% | +66.7% |
Q1 2016 | $137,000 | -56.9% | 4,000 | 0.0% | 0.13% | -60.0% |
Q4 2015 | $318,000 | +35.3% | 4,000 | 0.0% | 0.32% | +49.3% |
Q3 2015 | $235,000 | -8.6% | 4,000 | 0.0% | 0.21% | -12.4% |
Q2 2015 | $257,000 | +5.3% | 4,000 | 0.0% | 0.24% | -0.8% |
Q1 2015 | $244,000 | +4.3% | 4,000 | 0.0% | 0.24% | +11.5% |
Q4 2014 | $234,000 | – | 4,000 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
13D Management LLC | 415,055 | $9,268,000 | 4.85% |
Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |